Neuropharmacology continues to drive major advances in the treatment of neurological disorders through the development of safer, more effective, and targeted therapies. Emerging pharmaceutical innovations are transforming patient care and disease management.
This track focuses on novel drug development, targeted therapeutics, biologics, gene therapy, neuroprotective agents, precision medicine, and pharmacological management of neurological diseases. Discussions will highlight ongoing research and clinical applications.
Attendees will explore cutting-edge therapeutic innovations, personalized treatment approaches, medication safety, and future directions in neurological drug discovery and clinical practice.